Related Experiment Video
Updated: Jun 26, 2026

16:24
Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
Estrogen and progesterone interactive effects in postconfluent MCF-7 cell culture
O A Sukocheva1, Y Yang, J F Gierthy
1Division of Human Immunology, Hanson Institute for Cancer Research, IMVS, Adelaide, Australia. olga.sukocheva@imvs.sa.gov.au
Steroids
|January 21, 2009
Summary
Progesterone (P4) enhances 17beta-estradiol (E2)-induced breast cancer cell growth and differentiation. P4 also modifies cell adhesion and cytoskeleton proteins, potentially impacting tumor progression and metastasis.
Area of Science:
- Endocrinology
- Cell Biology
- Cancer Research
Background:
- 17beta-estradiol (E2) induces differentiation in MCF-7 human mammary carcinoma cells, forming multicellular nodules (foci).
- The combined effects of E2 and progesterone (P4) on this process are not fully understood.
Purpose of the Study:
- To investigate the synergistic effects of P4 and E2 on foci formation in MCF-7 cells.
- To elucidate the molecular mechanisms underlying P4- and E2-mediated changes in cell morphology, proliferation, and protein expression.
Main Methods:
- MCF-7 cells were treated with varying concentrations of E2 and P4.
- Changes in foci formation, cell division, and expression of cytoskeleton and adhesion proteins were analyzed.
- Receptor signaling involvement was assessed using antiprogestin and antiestrogen pretreatment.
Main Results:
- P4 dose-dependently potentiated E2-induced foci formation and enlarged existing foci.
- P4 altered cytoskeleton protein expression and accelerated cell division.
- Both P4 and E2 additively modulated adhesion proteins and stimulated tropomyosin (Tm) expression.
- Antihormone pretreatment blocked P4-dependent effects, confirming receptor involvement.
Conclusions:
- P4 significantly enhances E2-driven foci formation and phenotypic changes in breast cancer cells.
- Endocrine-regulated alterations in microfilament and adhesion proteins by P4 and E2 may influence tumorigenesis and metastasis.
- This study highlights novel endocrine-regulated molecular changes relevant to breast cancer progression.

